Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome
Clinical trial NCT03789175 · COMPLETED
Trial details
- NCT number
- NCT03789175
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-25
- Primary completion
- 2019-11-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.